Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

12 Sökresultat.
Relevans Bedömning Nya först Gamla först

Investigational product (Liver) GSK study Chronic Coronary Heart Disease NCT00799903

- 2018-01-04 - 1 Formulär, 2 Item-grupper, 8 Dataelement, 1 Språk
Item-grupper: Liver event during treatment period, Liver event after treatment period
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Investigational product (Liver)

Concomitant Medication SirTac NCT02936388 - Concomitant Medication

- 2017-12-03 - 1 Formulär, 1 Item-grupp, 12 Dataelement, 1 Språk
Item-grupp: Concomitant Medication
Study part: Concomitant Medication. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

End of Therapy SirTac NCT02936388 - End of Therapy

- 2017-11-28 - 1 Formulär, 1 Item-grupp, 12 Dataelement, 1 Språk
Item-grupp: Therapy end
Study part: End of Therapy. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Gastroenterology activity recording, University Hospital Cologne

- 2017-04-22 - 1 Formulär, 10 Item-grupper, 34 Dataelement, 1 Språk
Item-grupper: Gastroenterology service, New patient, Follow-up visit, Termination, Chemotherapy, Administration, Counseling, Diagnostics, Procedure, Chemotherapy
Hospital Routine Documentation Subform at the University Hospital Cologne. Original Form name: Leistungserf_Gastro

27920_Visit 1 EpimiRNA Study D Vagal Nerve Stimulation NCT02359188 - Visit 1 EpimiRNA Study D Vagal Nerve Stimulation NCT02359188

- 2017-12-19 - 1 Formulär, 7 Item-grupper, 21 Dataelement, 1 Språk
Item-grupper: Administrative data, First blood sample, Attachment of ear electrode of tVNS device, Test meal, Second blood sample, Adverse events and comments, Signature physician
NCT02359188 Influence of Transcutaneous Vagal Nerve Stimulation on Expression of microRNA, Cytokines, Chemokines and Neuropeptides as Well as Cerebral Resting State and Gastric Motility Quellenangabe: Dr. Sebastian Bauer Philipps-Universität Marburg

27924_Visit 2 EpimiRNA Study D Vagal Nerve Stimulation NCT02359188 - Visit 2 EpimiRNA Study D Vagal Nerve Stimulation NCT02359188

- 2017-12-19 - 1 Formulär, 8 Item-grupper, 25 Dataelement, 1 Språk
Item-grupper: Administrative data, First blood sample, tVNS / sham-tVNS, Test meal, Second blood sample, MRI, Adverse events and comments, Signature physician
NCT02359188 Influence of Transcutaneous Vagal Nerve Stimulation on Expression of microRNA, Cytokines, Chemokines and Neuropeptides as Well as Cerebral Resting State and Gastric Motility Quellenangabe: Dr. Sebastian Bauer Philipps-Universität Marburg

Visit 2 EpimiRNA Study D Vagal Nerve Stimulation NCT02359188

- 2017-12-05 - 1 Formulär, 8 Item-grupper, 25 Dataelement, 1 Språk
Item-grupper: Administrative data, First blood sample, tVNS / sham-tVNS, Test meal, Second blood sample, MRI, Adverse events and comments, Signature physician
NCT02359188 Influence of Transcutaneous Vagal Nerve Stimulation on Expression of microRNA, Cytokines, Chemokines and Neuropeptides as Well as Cerebral Resting State and Gastric Motility Quellenangabe: Dr. Sebastian Bauer Philipps-Universität Marburg

WTZ-GIST-09-01 (Imatinib + LBH589) Dosage administration record 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Dosage administration record 2009-011417-24

- 2016-12-15 - 1 Formulär, 2 Item-grupper, 20 Dataelement, 1 Språk
Item-grupper: Dosage administration, Contribution of study medication
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Concomitant Therapies 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Concomitant Therapies 2009-011417-24

- 2016-12-02 - 1 Formulär, 1 Item-grupp, 8 Dataelement, 1 Språk
Item-grupp: Concomitant Therapies
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 Pharmacokinetics 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Cycle 1 Pharmacokinetics 2009-011417-24

- 2016-11-23 - 1 Formulär, 1 Item-grupp, 7 Dataelement, 1 Språk
Item-grupp: Pharmacokinetics (PK)
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Prior Antineoplastic Treatment 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Prior Antineoplastic Treatment 2009-011417-24

- 2016-11-23 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Prior Antineoplastic Treatment - Chemotherapy, Prior Antineoplastic Treatment - Surgery
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

REGIMS Registry Baseline - Baseline Main Sheet

- 2021-09-20 - 3 Formulär, 25 Item-grupper, 116 Dataelement, 2 Språk
Item-grupper: Ein-Ausschlusskriterien, Patientendaten, Krankheitsspezifische Angaben, EDSS-Score vor 12 Monaten, Heutige Scores der Funktionssysteme, Frühere verlaufsmodifizierende MS-Therapien, Aktuelle MS-Therapie, WeitereErkrankungen, Herz- / Kreislauferkrankungen, Stoffwechselerkrankungen, Infektionserkrankungen, Gastrointestinale Erkrankungen, Neurologische / Psychiatrische Erkrankungen, Allergien, Urogenitale Erkrankungen, Autoimmunerkrankungen, Blutbild / Labor, Allgemeine Symptome, Operation, Krebserkrankungen, Welche Therapien wurden aufgrund der Krebserkrankung durchgeführt?, Andere Erkrankung, Keine Vorerkrankungen aus diesen obigen Krankheitsgruppen/Erkrankungen bekannt, Schwangerschaft, Biologisches Material (z.B. Blut)
Baseline items for semantic analysis of the Multiple sclerosis immunotherapy registry REGIMS of the Institute of Epidemiology and Social Medicine of the University Hospital Münster provided by Prof. Dr. Klaus Berger and Dr. Maximov Stanislav.

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial